Envista Holdings Corp. (NVST)

Envista Holdings Corp. experienced several notable events and financial performances over the past six months. In Q3 2025, Envista reported strong results with core sales growth of 5.0% for the first nine months and an adjusted EBITDA increase of 27% year-on-year. In Q2 2025, Envista reported total revenue of $682 million and core revenue growth of 5.6% year-over-year. In Q1 2025, Envista beat Wall Street's revenue expectations, though sales fell by 1.1% year-on-year to $616.9 million. The company invested an incremental $25 million in commercial coverage, clinical education, and new product development in 2024 to fuel growth. Envista's stock price has increased by 21.85% over the last 12 months, with a year-to-date return of 6.76%.

The global dental market is characterized as a structurally attractive and consistent grower, typically expanding at a rate of 3% to 5% annually. Demand for dental care is generally stable, with dental spend often exceeding GDP growth. Envista's broad portfolio and global reach allow it to capitalize on this stable demand, and management believes the dental market shows signs of returning to its long-term consistent growth rate.

Envista Holdings Corp. (NVST) is a global dental products company spun off from Danaher Corporation in 2019. It operates within the Healthcare sector, focusing on dental consumables, equipment, and services. The company has two primary segments: Specialty Products & Technologies, which includes dental implant systems, regenerative solutions, and orthodontic products; and Equipment & Consumables, which provides dental equipment and supplies. Envista owns over 30 trusted dental brands and is investing in digital dentistry, including AI-powered diagnostics.

Envista Holdings Corp. has a significant global presence, operating across approximately 180 countries, with its products used in an estimated 90% of dental clinics worldwide. The company generates most of its revenue from North America, followed by Western Europe, and other developed and emerging markets, including Asia-Pacific. Roughly half of its sales come from the U.S., with the balance spread across Europe and developing markets.

Envista Holdings Corp. maintains a portfolio of highly reputable legacy brands, fostering trust among dental professionals. The company's commitment to research and development, with over 1,500 patents, contributes to its strong reputation for innovation. In 2025, Envista focused on enhancing its reputation through the release of its 2024 Sustainability Report, donating over $1.8 million to communities through the Envista Smile Project, and being recognized as a top employer. Major product launches also demonstrate a commitment to innovation.

Envista Holdings Corp.'s ownership is primarily dominated by institutional investors. As of January 5, 2026, there are 677 institutional owners holding a total of 254,507,257 shares. Major institutional owners include BlackRock, Inc., The Vanguard Group, Inc., Ariel Investments, LLC, and Morgan Stanley. Significant individual shareholders include Lin Tan and Lihui Song, each owning 18.78% of the shares.